title: Cyclophosphamide therapy is effective for bronchiolitis obliterans occurring as a late manifestation of lupus erythematosus.
authors.forename: F
authors.initials: F
authors.lastname: Weber
authors.forename: C
authors.initials: C
authors.lastname: Prior
authors.forename: E
authors.initials: E
authors.lastname: Kowald
authors.forename: M
authors.initials: M
authors.lastname: Schmuth
authors.forename: N
authors.initials: N
authors.lastname: Sepp
mesh_terms: D000328:Adult; D001327:Autoimmune Diseases / Q000188:drug therapy*; D001989:Bronchiolitis Obliterans / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000150:complications*; D008875:Middle Aged
chemical_list: D007166:Immunosuppressive Agents; D003520:Cyclophosphamide